Dr Reddys Laboratories Ltd's share price has fallen by -0.41%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,156.40, and market participants are assessing the implications. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.